Pharmacist-provided Medication Therapy Management (MTM) program impacts outcomes for employees with diabetes

Population Health Management

Volumn 17, Issue 1, 2014, Pages 21-27

  Pinto, Sharrel L ^a   Kumar, Jinender ^a   Partha, Gautam ^a   Bechtol, Robert A ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; SELF CARE;

EID: 84894194901     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2012.0124     Document Type: Article

References (31)

1. Lipton HL. Pharmacists and health reform: Go for it! Pharmacotherapy 2010;30:967-972.
2. Cutler TW. The pharmacy profession and health care reform: Opportunities and challenges during the next decade. J Am Pharm Assoc 2011;51:477-481.
3. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166:955-964.
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615.
5. Beaulieu N, Cutler D, Ho K, et al. The business case for diabetes disease management for managed care organizations. Forum Health Econ Policy 2006;9:Article
6. Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ 2011;14:646-655.
7. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
8. Sigur{Eth}ardóttir ÁK. Self-care in diabetes: Model of factors affecting self-care. J Clin Nurs 2005;14:301-314.
9. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 2000;13:36.
10. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238-2243.
11. Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings. Health Aff (Millwood) 2010;29:304-311.
12. Naydeck BL, Pearson JA, Ozminkowski RJ, Day BT, Goetzel RZ. The impact of the Highmark employee wellness programs on 4-year healthcare costs. J Occup Environ Med 2008;50:146-156.
13. Fera T, Bluml BM, Ellis WM, Schaller CW, Garrett DG. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc (2003) 2008;48:181-190.
14. American Pharmacists Association. Medication Therapy Management Digest: Perspectives on 2009. A Year of Changing Opportunities. Washington, DC: American Pharmacists Association; March 2010.
15. Gore PR, Madhavan S. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines. J Clin Pharm Ther 1994;19:17-25.
16. Drab S. Translating clinical guidelines into clinical practice: Role of the pharmacist in type 2 diabetes management. J Am Pharm Assoc (2003) 2009;49:e152-e162.
17. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:173-184.
18. Medication therapy management services: A critical review. J Am Pharm Assoc (2003) 2005;45:580-587.
19. Persell SD, Keating NL, Landrum MB, et al. Relationship of diabetes-specific knowledge to self-management activities, ambulatory preventive care, and metabolic outcomes. Prev Med 2004;39:746-752.
20. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: The Minnesota experience. J Am Pharm Assoc (2003) 2008;48:203-211; 3 p following 211.
21. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-412.
22. Wyne K. Information technology for the treatment of diabetes: Improving outcomes and controlling costs. J Manag Care Pharm 2008;14:S12-S17.
23. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: A prospective observational study (UKPDS 75). Diabetologia 2006;49:1761-1769.
24. KarlssonML, Bjorklund C, Jensen I. The effects of psychosocial work factors on production loss, and the mediating effect of employee health. J Occup Environ Med 2010;52:310-317.
25. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004; 46:398-412.
26. Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 2008;87:1254-1261.
27. Hordern MD, Coombes JS, Cooney LM, Jeffriess L, Prins JB, Marwick TH. Effects of exercise intervention on myocardial function in type 2 diabetes. Heart. 2009;95:1343-1349.
28. Miller ER 3rd, Erlinger TP, Young DR, et al. Results of the diet, exercise, and weight loss intervention trial (DEW-IT). Hypertension 2002;40:612-618.
29. Ronnemaa T, Hamalainen H, Toikka T, Liukkonen I. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care 1997;20:1833-1837.
30. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006;63: 2116-2122.
31. Garrett DG, Bluml BM. Patient self-management program for diabetes: First-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc (2003). 2005;45:130-137.